Monitoring heart rhythms after a heart attack
Arrhythmia Detection After Myocardial Infarction Trial
This study tests if using a heart monitor after a heart attack can help doctors catch dangerous heart rhythms early and improve care for patients at risk of sudden cardiac death.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 200 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Trial ID | NCT05073419 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the use of an implantable cardiac monitor (ICM) in patients who have experienced an acute myocardial infarction (AMI) to assess and manage their risk of sudden cardiac death. The study aims to determine if early monitoring can lead to better patient management and outcomes by identifying arrhythmias that may require intervention. Participants will receive standard care along with ICM implantation within 21 days of their AMI. The trial focuses on patients with ventricular tachycardia or fibrillation, who are at higher risk for sudden cardiac death.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who have experienced a recent AMI and are willing to undergo ICM implantation within 21 days.
Not a fit: Patients with existing implantable cardiac devices or those who cannot receive an ICM within the specified timeframe may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve survival rates and management strategies for patients recovering from a heart attack.
How similar studies have performed: Previous studies have shown promising results with similar monitoring approaches, indicating potential for success in this trial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults, age 18 years or older * AMI (STEMI and NSTEMI) * Willing to give written informed consent * Expected discharge from hospital within 7 days of AMI * Willing to receive ICM insertion within 21 days of index AMI Exclusion Criteria: * Existing pacemaker, ICD, ICM, or any other implantable cardiac electronic device * Pregnant * Index AMI was more than 21 days * Unwilling/cannot insert ICM within 21 days post AMI * Planned ICD implant, planned CABG or any open-heart surgery (e.g. for severe valvular disease)
Where this trial is running
Pittsburgh, Pennsylvania
- UPMC Presbyterian Hospital — Pittsburgh, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Samir F Saba, MD — University of Pittsburgh Medical Center
- Study coordinator: Samir F Saba, MD
- Email: sabas@upmc.edu
- Phone: 412 647 2695
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.